Liquidia Corp (LQDA) Stock Price, Quote & News

Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intr...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 919 328 4400

Fax: 919 328 4402

Website: www.liquidia.com

Address:

419 Davis Drive, Suite 100, Morrisville, United States

CrispDry Jun. 24 at 8:23 PM

$LQDA felt like I had to dip out. In since 20s and kept averaging up my core holdings. Booked roughly $200K Bless you all and good luck on the next one

1 · Reply

leafmccarthurJD Jun. 24 at 8:18 PM

$LQDA at this point I really respect Steve Mano. You gotta understand that this guy doesn’t give up. We’re up 700% in 2 1/2 years and he’s STILL GOING. His parents raised a strong willed retard. @stevemano tell me more about yourself. What kinda upbringing did you have to be this stupid?

0 · Reply

iwtd Jun. 24 at 7:48 PM

$LQDA - new price target for this biotechnology stock. No guarantee it will get there.

0 · Reply

Gambaa Jun. 24 at 5:29 PM

$LQDA Happy longest court ruling ever day! What a treat if we got a decision at aths!

0 · Reply

Wolf1971 Jun. 24 at 5:11 PM

$LQDA are they approved for their single product that they allegedly got the inspiration and chemical formula from UTHR? If so kudos! Like Rite Cola or Sunnshine Brand ketchup to Coke and Heinz! Well done Liquidass what’s next knockoff diarrhea cures?

0 · Reply

stevemano Jun. 24 at 3:37 PM

$LQDA still

1 · Reply

leafmccarthurJD Jun. 24 at 2:57 PM

$LQDA Steve Mano has probably lost his mind. He was bashing all the way back at 7 bucks!! Coulda made an easy 50k instead he chose to bitch. SAD

0 · Reply

KeelinTime Jun. 24 at 12:33 PM

$LQDA

0 · Reply

stevemano Jun. 24 at 10:49 AM

$LQDA fundamentally a complete scam with tons of pumpers

1 · Reply

BullRun4 Jun. 24 at 12:29 AM

$LQDA $80 very soon!!

0 · Reply

Liquidia price target raised to $109 from $59 at BTIG

Jun 16, 2026, 4:30 PM EDT - 8 days ago

Liquidia Transcript: AGM 2026

Jun 11, 2026, 8:30 AM EDT - 13 days ago

Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions

2026-06-08T13:08:28.000Z - 16 days ago

Liquidia announces inclusion in S&P SmallCap 600 Index

Jun 8, 2026, 8:30 AM EDT - 16 days ago

Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index

2026-06-05T10:55:08.000Z - 19 days ago

Liquidia price target raised to $75 from $67 at H.C. Wainwright

2026-06-04T19:30:40.000Z - 20 days ago

Raymond James sees positive readthrough for Liquidia from Hikma v. Amarin

2026-06-04T16:09:07.000Z - 20 days ago

Liquidia rises 17.6%

Jun 3, 2026, 12:45 PM EDT - 21 days ago

Liquidia Transcript: Jefferies Global Healthcare Conference 2026

May 27, 2026, 8:30 AM EDT - 4 weeks ago

Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference

May 19, 2026, 9:30 AM EDT - 5 weeks ago

Liquidia Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference

May 13, 2026, 11:40 AM EDT - 6 weeks ago

Liquidia Transcript: Bank of America Global Healthcare Conference 2026

2026-05-12T18:47:33.000Z - 6 weeks ago

Liquidia price target raised to $67 from $55 at H.C. Wainwright

2026-05-12T11:38:21.000Z - 6 weeks ago

Liquidia price target raised to $62 from $51 at Wells Fargo

2026-05-11T21:57:52.000Z - 6 weeks ago

Liquidia price target raised to $60 from $57 at Jefferies

May 11, 2026, 8:30 AM EDT - 6 weeks ago

Liquidia Earnings Call Transcript: Q1 2026

May 11, 2026, 8:30 AM EDT - 6 weeks ago

Liquidia Earnings release: Q1 2026

May 11, 2026, 8:30 AM EDT - 6 weeks ago

Liquidia Quarterly report: Q1 2026

May 11, 2026, 8:30 AM EDT - 6 weeks ago

Liquidia Slides: Q1 2026

2026-05-11T11:28:55.000Z - 6 weeks ago

Liquidia reports Q1 EPS 52c, consensus 41c

May 11, 2026, 6:30 AM EDT - 6 weeks ago

Liquidia Corporation Reports First Quarter 2026 Financial Results

May 6, 2026, 8:30 AM EDT - 7 weeks ago

Liquidia Corporation to Participate in Upcoming Investor Conferences

May 4, 2026, 8:30 AM EDT - 7 weeks ago

Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026

Apr 24, 2026, 8:00 AM EDT - 2 months ago

Liquidia Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 2 months ago

Liquidia Proxy statement: Proxy filing

Apr 15, 2026, 12:45 PM EDT - 2 months ago

Liquidia Transcript: 25th Annual Needham Virtual Healthcare Conference

2026-03-23T10:32:21.000Z - 3 months ago

Liquidia price target raised to $51 from $44 at Wells Fargo

INSM

2026-03-16T14:55:09.000Z - 3 months ago

Liquidia Technologies put volume heavy and directionally bearish

2026-03-12T11:52:04.000Z - 3 months ago

Liquidia price target raised to $19 from $16 at Oppenheimer

2026-03-06T15:06:42.000Z - 3 months ago

Liquidia rises 7.7%

2026-03-06T11:16:01.000Z - 3 months ago

Liquidia price target raised to $55 from $50 at H.C. Wainwright

2026-03-05T21:46:18.000Z - 3 months ago

Liquidia files automatic mixed securities shelf

Mar 5, 2026, 8:30 AM EST - 3 months ago

Liquidia Earnings Call Transcript: Q4 2025

Mar 5, 2026, 8:30 AM EST - 3 months ago

Liquidia Annual report: Q4 2025

Mar 5, 2026, 8:30 AM EST - 3 months ago

Liquidia Earnings release: Q4 2025

Mar 5, 2026, 8:30 AM EST - 3 months ago

Liquidia Slides: Q4 2025

2026-03-05T11:37:50.000Z - 3 months ago

Liquidia reports Q4 EPS 15c, consensus 33c

Mar 5, 2026, 6:30 AM EST - 3 months ago

Liquidia Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Feb 26, 2026, 7:00 AM EST - 4 months ago

Liquidia Corporation to Report Full Year 2025 Financial Results on March 5, 2026

Jan 14, 2026, 8:15 PM EST - 5 months ago

Liquidia Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 8:15 PM EST - 5 months ago

Liquidia Slides: 44th Annual J.P. Morgan Healthcare Conference

Nov 18, 2025, 8:00 AM EST - 7 months ago

Liquidia Transcript: Jefferies London Healthcare Conference 2025

Nov 10, 2025, 4:15 PM EST - 8 months ago

Liquidia Transcript: UBS Global Healthcare Conference 2025

Nov 3, 2025, 8:30 AM EST - 8 months ago

Liquidia Earnings Call Transcript: Q3 2025

Nov 3, 2025, 8:30 AM EST - 8 months ago

Liquidia Quarterly report: Q3 2025

Nov 3, 2025, 8:30 AM EST - 8 months ago

Liquidia Earnings release: Q3 2025

Nov 3, 2025, 8:30 AM EST - 8 months ago

Liquidia Slides: Q3 2025

Nov 3, 2025, 8:00 AM EST - 8 months ago

Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences

Oct 28, 2025, 3:00 PM EDT - 8 months ago

Liquidia Transcript: R&D Day 2025

Oct 28, 2025, 3:00 PM EDT - 8 months ago

Liquidia Slides: FY 2025

Oct 27, 2025, 8:30 AM EDT - 8 months ago

Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025

Oct 7, 2025, 6:30 AM EDT - 9 months ago

Liquidia Corporation to Host R&D Day in New York City on October 28, 2025

Sep 3, 2025, 3:45 PM EDT - 10 months ago

Liquidia Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 27, 2025, 8:30 AM EDT - 10 months ago

Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

Aug 12, 2025, 8:30 AM EDT - 11 months ago

Liquidia Earnings Call Transcript: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 11 months ago

Liquidia Quarterly report: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 11 months ago

Liquidia Earnings release: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 11 months ago

Liquidia Slides: Q2 2025

Aug 12, 2025, 6:30 AM EDT - 11 months ago

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Jun 23, 2025, 4:34 PM EDT - 1 year ago

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

Jun 4, 2025, 11:05 AM EDT - 1 year ago

Liquidia Transcript: Jefferies Global Healthcare Conference 2025

Jun 2, 2025, 6:30 AM EDT - 1 year ago

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

May 28, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference

May 27, 2025, 8:30 AM EDT - 1 year ago

Liquidia Transcript: Status Update

May 27, 2025, 8:30 AM EDT - 1 year ago

Liquidia Slides: Status Update

May 23, 2025, 2:28 PM EDT - 1 year ago

U.S. FDA Approves Liquidia's YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

May 13, 2025, 4:40 PM EDT - 1 year ago

Liquidia Transcript: BofA Securities 2025 Healthcare Conference

May 12, 2025, 6:00 AM EDT - 1 year ago

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Quarterly report: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings release: Q1 2025

May 8, 2025, 6:30 AM EDT - 1 year ago

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

May 2, 2025, 5:28 PM EDT - 1 year ago

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

May 1, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Liquidia Proxy statement: Proxy Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Liquidia Proxy statement: Proxy Filing

Apr 9, 2025, 8:45 AM EDT - 1 year ago

Liquidia Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 10:33 AM EDT - 1 year ago

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 28, 2025, 9:30 AM EDT - 1 year ago

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings Call Transcript: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Annual report: Q4 2024

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Liquidia Earnings release: Q4 2024

Mar 19, 2025, 8:00 AM EDT - 1 year ago

Liquidia Registration statement: Registration Filing

Mar 19, 2025, 6:30 AM EDT - 1 year ago

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

Mar 12, 2025, 8:00 AM EDT - 1 year ago

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

Jan 15, 2025, 12:45 PM EST - 1 year ago

Liquidia Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 12:45 PM EST - 1 year ago

Liquidia Slides: FY 2025

Nov 19, 2024, 3:00 PM EST - 1 year ago

Liquidia Transcript: Stifel 2024 Healthcare Conference

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Earnings Call Transcript: Q3 2024

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Quarterly report: Q3 2024

Nov 13, 2024, 8:30 AM EST - 1 year ago

Liquidia Earnings release: Q3 2024

Nov 13, 2024, 6:30 AM EST - 1 year ago

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Oct 7, 2024, 10:00 AM EDT - 1 year ago

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics' Patent

Oct 2, 2024, 6:00 AM EDT - 1 year ago

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

Sep 30, 2024, 8:00 AM EDT - 1 year ago

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

Sep 19, 2024, 1:30 PM EDT - 1 year ago

Liquidia Transcript: 2024 Cantor Fitzgerald Global Healthcare Conference

Sep 16, 2024, 9:41 AM EDT - 1 year ago

Court Finds United Therapeutics' Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million

CrispDry Jun. 24 at 8:23 PM

$LQDA felt like I had to dip out. In since 20s and kept averaging up my core holdings. Booked roughly $200K Bless you all and good luck on the next one

1 · Reply

leafmccarthurJD Jun. 24 at 8:18 PM

0 · Reply

iwtd Jun. 24 at 7:48 PM

$LQDA - new price target for this biotechnology stock. No guarantee it will get there.

0 · Reply

Gambaa Jun. 24 at 5:29 PM

$LQDA Happy longest court ruling ever day! What a treat if we got a decision at aths!

0 · Reply

Wolf1971 Jun. 24 at 5:11 PM

0 · Reply

stevemano Jun. 24 at 3:37 PM

$LQDA still

1 · Reply

leafmccarthurJD Jun. 24 at 2:57 PM

$LQDA Steve Mano has probably lost his mind. He was bashing all the way back at 7 bucks!! Coulda made an easy 50k instead he chose to bitch. SAD

0 · Reply

KeelinTime Jun. 24 at 12:33 PM

$LQDA

0 · Reply

stevemano Jun. 24 at 10:49 AM

$LQDA fundamentally a complete scam with tons of pumpers

1 · Reply

BullRun4 Jun. 24 at 12:29 AM

$LQDA $80 very soon!!

0 · Reply

chinchinbull Jun. 23 at 4:23 PM

$LQDA very interesting 🧐 . What are the trader's prospects, ascending to more greatness or descending to chaos?

1 · Reply

lsb1201030758 Jun. 23 at 3:11 PM

$LQDA Complete and utter beast mode...

0 · Reply

JFais Jun. 23 at 1:43 PM

$LQDA my #9 position at just under 8% PW

0 · Reply

KeelinTime Jun. 23 at 1:13 PM

$LQDA

0 · Reply

stevemano Jun. 23 at 12:39 PM

$LQDA

0 · Reply

stevemano Jun. 23 at 12:37 PM

$LQDA look for this overstuffed piggy 🐷 to crash 💥 ^GSPC is down 0.37% to $7,472.79. Check it out on Yahoo Finance https://finance.yahoo.com/quote/%5EGSPC?p=%5EGSPC

0 · Reply

stevemano Jun. 23 at 9:20 AM

$LQDA highly applicable here on this pump n dump scam.

0 · Reply

jlonards Jun. 23 at 2:39 AM

$LQDA Put time

0 · Reply

JamesTaulman Jun. 23 at 2:36 AM

$LQDA – MON: Very Bullish Action With Volume-Backed Gains and a New High Close Latest Chart Update: LQDA 9:05 PM – We are currently reporting on this stock as an active holding and continue to monitor the stock closely for any technical SELL SIGNALS. The focus always remains on price/volume action around key support levels, including the 10 DMA, 50 DMA, and any nearby trendline or ROUND-$ support. https://buyingbreakouts.com/mon-6-22-lqda-very-bullish-action-with-volume-backed-gains-and-a-new-high-close/

0 · Reply

grampslol Jun. 22 at 7:19 PM

$MNKD here it sits in red and $LQDA is rocketing in the land of big green ...

0 · Reply

Gambaa Jun. 22 at 7:05 PM

$LQDA Wow crazy strength, market catching on to how cheap this is.

0 · Reply

Wolf1971 Jun. 22 at 4:59 PM

$LQDA one trick pony with a garbage product

3 · Reply

Market Cap	6.58B
Revenue (ttm)	158.32M
Net Income (ttm)	-68.92M
EPS (ttm)	N/A
PE Ratio	507.64
Forward PE	23.93
Profit Margin	-43.53%
Debt to Equity Ratio	1.64

Volume	2,086,800
Avg Vol	1,903,068
Day's Range	N/A - N/A
Shares Out	88.93M
Stochastic %K	78%
Beta	0.58
Analysts	Strong Sell
Price Target	$72.38